Akara has raised new funding to deploy privacy first AI in healthcare, bypassing the surveillance concerns of traditional camera systems.
Most hospital AI solutions rely on cameras, and most patients hate being watched. Akara just raised $5.5 million to change that dynamic by building a system that sees movement without seeing faces. The Los Angeles based startup announced the funding on November 11, 2026, bringing its total capital to $12.3 million. It is a significant move for a company trying to solve a very specific problem in healthcare operations.
The core tension in modern hospitals is simple. Staff are overwhelmed by administrative tasks, and the tools meant to help often feel invasive. Akara’s approach uses thermal sensors and edge AI to track how clinical spaces are used. This allows hospitals to optimize workflow without storing detailed visual images of patients or staff. It is a quiet revolution in how we think about data in sensitive environments.
The privacy problem with smart hospitals
Existing solutions for capturing activity in clinical spaces typically rely on video feeds. These are costly to deploy and raise immediate privacy concerns for both patients and healthcare workers. Akara combines thermal sensing with edge AI to detect activity without capturing detailed visual images. The processing runs directly on each device, which limits sensitive data transmission and reduces infrastructure requirements.
This technical choice is the heart of their value proposition. By keeping the data local and abstracting the visual details, they create a foundation for physical AI across everyday hospital operations. It makes deployment simpler and more affordable to scale. For a hospital administrator, that means less friction in getting the technology approved by legal and ethics committees.

Why the funding matters now
The timing of this raise is not accidental. More than 40% of U.S. hospitals are operating at a loss, according to the company’s announcement. Providers face growing pressure to improve efficiency without hiring more staff. Manual documentation and fragmented communication consume valuable time that should be spent on patient care.
Akara’s software acts like an air traffic controller. It detects key events and notifies staff when they are needed. AI agents allow staff to ask questions about the data in natural language and generate reports. This reduces the effort required to turn operational information into practical improvements. It is a direct response to the labor bottlenecks that are straining the healthcare system right now.

The investors behind the tech
The round was led by Locke Health, with participation from VTC Ventures, the EIC Fund, CommonKind, and NovaVector Holdings. Existing investors ACT, Atlantic Bridge, and Enterprise Ireland also participated. The backing from three healthcare specialist venture capital firms suggests a strong belief in the commercial viability of this specific approach.
VTC Ventures connects Akara to the Virginia Tech and Carilion Clinic ecosystem. This kind of strategic connection is often more valuable than the cash itself. It provides a pathway for real world testing and adoption. For a startup in healthcare, access to clinical partners is the difference between a promising product and a deployed solution.

What this means for the future of care
Dr. Conor McGinn, co-founder and CEO of Akara, said that hospitals need to do more with existing staff and resources. He wants to give teams time back through technology that protects privacy, is affordable, and is straightforward to deploy. This is a clear mission statement that resonates with the current mood in the industry.
The future of hospital technology may not be about replacing humans with robots, but about giving humans better information. By using sensors that respect privacy, Akara is positioning itself as a partner in the healthcare ecosystem rather than a surveillant. As the pressure on hospital budgets continues, this approach could become the standard for operational AI.
Frequently asked questions

Keep subscribing to Róisín ByrneHer next filing reaches you the moment it publishes, on her own subdomain.
Subscribe
